These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19130230)

  • 1. Cell death in hematological tumors.
    Fulda S
    Apoptosis; 2009 Apr; 14(4):409-23. PubMed ID: 19130230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic opportunities for counteracting apoptosis resistance in childhood leukaemia.
    Fulda S
    Br J Haematol; 2009 May; 145(4):441-54. PubMed ID: 19298593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting apoptosis pathways for the treatment of pediatric cancers.
    Fulda S
    Pediatr Blood Cancer; 2009 Oct; 53(4):533-6. PubMed ID: 19148945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting apoptosis as an approach for gastrointestinal cancer therapy.
    Qiao L; Wong BC
    Drug Resist Updat; 2009 Jun; 12(3):55-64. PubMed ID: 19278896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting apoptosis proteins in hematological malignancies.
    Droin N; Guéry L; Benikhlef N; Solary E
    Cancer Lett; 2013 May; 332(2):325-34. PubMed ID: 21767908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging targets for hematological malignancies.
    Cilloni D; Frassoni F; Saglio G
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):548-58. PubMed ID: 20812146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell death and survival signaling in oncogenesis.
    Fulda S
    Klin Padiatr; 2010 Nov; 222(6):340-4. PubMed ID: 20862627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Bcl-2 family of proteins in malignancy.
    Baliga BC; Kumar S
    Hematol Oncol; 2002 Jun; 20(2):63-74. PubMed ID: 12111869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 family members as molecular targets in cancer therapy.
    Marzo I; Naval J
    Biochem Pharmacol; 2008 Oct; 76(8):939-46. PubMed ID: 18638457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms.
    Reed JC
    Nat Clin Pract Oncol; 2006 Jul; 3(7):388-98. PubMed ID: 16826219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
    Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
    Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor of apoptosis proteins as targets for anticancer therapy.
    Fulda S
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective anticancer strategies via intervention of the death pathways relevant to cell transformation.
    Li QX; Yu DH; Liu G; Ke N; McKelvy J; Wong-Staal F
    Cell Death Differ; 2008 Aug; 15(8):1197-210. PubMed ID: 18437165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family.
    Shangary S; Johnson DE
    Leukemia; 2003 Aug; 17(8):1470-81. PubMed ID: 12886234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting apoptosis pathways in childhood malignancies.
    Fulda S
    Cancer Lett; 2013 May; 332(2):369-73. PubMed ID: 21036468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential diagnostic, prognostic and therapeutic implications of some new regulatory proteins in hematologic malignancies.
    Milosević D
    J Exp Clin Cancer Res; 2000 Jun; 19(2):175-81. PubMed ID: 10965815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ways to sensitise gastrointestinal cancer to apoptosis.
    Schulze-Bergkamen H; Weinmann A; Moehler M; Siebler J; Galle PR
    Gut; 2009 Jul; 58(7):1010-24. PubMed ID: 19520891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia.
    Loeder S; Zenz T; Schnaiter A; Mertens D; Winkler D; Döhner H; Debatin KM; Stilgenbauer S; Fulda S
    Cancer Res; 2009 Dec; 69(23):8977-86. PubMed ID: 19920200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis in leukemia: from molecular pathways to targeted therapies.
    Schimmer AD
    Best Pract Res Clin Haematol; 2008 Mar; 21(1):5-11. PubMed ID: 18342807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytochrome c to indicate the extent of ongoing tumor cell death.
    Osaka A; Hasegawa H; Tsuruda K; Inokuchi N; Yanagihara K; Yamada Y; Aoyama M; Sawada T; Kamihira S
    Int J Lab Hematol; 2009 Jun; 31(3):307-14. PubMed ID: 18279425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.